Del Trezise is currently Head of Applications, BioAnalytics at Sartorius AG, a leading international pharmaceutical and laboratory solution provider. Trained to PhD. level in pharmacology and physiology, his postdoctoral research at the University of Cambridge, UK focused on cell signaling pathways in sensory neurons. He went on to pursue a 15-year career in applied drug discovery across a number of divisions of GlaxoSmithKline including senior positions in Neuroscience, Biological Reagents and Assay Development, and Compound Screening. In 2009 Del co-founded Essen BioScience Ltd, a specialist cell-based technology company, which was subsequently acquired by Sartorius AG in 2017. He is a highly experienced leader in the field of cell biology and assay technology and has co-authored more than 50 original papers and articles in this area.